Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections

ObjectivesThis study aims to compare the diagnostic efficiency and consistency of metagenomic next-generation sequencing (mNGS) and targeted next-generation sequencing (tNGS) in patients with lower respiratory tract fungal infections.MethodsA total of 115 patients with probable pulmonary infection b...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiyang Chen, Xin Liu, Li Tan, Xing Lyu, Qichen Long, Weimin Wu, Zhe Guo, Zhenni Liu, Ziyang Li, Min Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1534519/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325486363115520
author Zhiyang Chen
Zhiyang Chen
Zhiyang Chen
Xin Liu
Xin Liu
Xin Liu
Li Tan
Li Tan
Li Tan
Xing Lyu
Xing Lyu
Xing Lyu
Qichen Long
Qichen Long
Qichen Long
Weimin Wu
Weimin Wu
Weimin Wu
Zhe Guo
Zhe Guo
Zhe Guo
Zhenni Liu
Zhenni Liu
Zhenni Liu
Ziyang Li
Ziyang Li
Ziyang Li
Min Hu
Min Hu
Min Hu
author_facet Zhiyang Chen
Zhiyang Chen
Zhiyang Chen
Xin Liu
Xin Liu
Xin Liu
Li Tan
Li Tan
Li Tan
Xing Lyu
Xing Lyu
Xing Lyu
Qichen Long
Qichen Long
Qichen Long
Weimin Wu
Weimin Wu
Weimin Wu
Zhe Guo
Zhe Guo
Zhe Guo
Zhenni Liu
Zhenni Liu
Zhenni Liu
Ziyang Li
Ziyang Li
Ziyang Li
Min Hu
Min Hu
Min Hu
author_sort Zhiyang Chen
collection DOAJ
description ObjectivesThis study aims to compare the diagnostic efficiency and consistency of metagenomic next-generation sequencing (mNGS) and targeted next-generation sequencing (tNGS) in patients with lower respiratory tract fungal infections.MethodsA total of 115 patients with probable pulmonary infection between September 2022 and April 2023 were enrolled at the Second Xiangya Hospital, Changsha, China, of which 61 were clinically diagnosed with invasive pulmonary fungal infection (IPFI) and 54 were non-IPFI cases. All patients received bronchoalveolar lavage, with mNGS, tNGS, and cultures being conducted paralleled. Diagnostic effectiveness and consistency in detecting microorganisms were compared.ResultsBoth mNGS and tNGS showed high sensitivity rates of 95.08% each, with specificity of 90.74% and 85.19%, respectively. They also demonstrated positive predictive values (PPVs) of 92.1% and 87.9% and negative predictive values (NPVs) of 94.2% and 93.9%, respectively, in diagnosing IPFI. The sensitivity and NPV of mNGS and tNGS were superior to that of any individual or combined conventional microbiological tests (CMTs) (P < 0.05). The consistency of culture with mNGS and tNGS was 48.70% and 50.43%, respectively. For fungal detection, Pneumocystis jirovecii (26/61, 42.6%; and 28/61, 45.9%), Candida albicans (19/61, 31.1%; and 21/61, 34.4%), and Aspergillus fumigatus (16/61, 26.2%; and 15/61, 24.6%) are most prevalent for mNGS and tNGS in enrolled cases, and the detection rate was greatly higher than that of culture. Furthermore, mNGS and tNGS were capable of diagnosing mixed infections in 65 and 55 out of the 115 cases, whereas only nine cases of bacterial-fungal infection were detected by culture.ConclusionThe diagnostic efficacy of mNGS and tNGS was comparable to that of identified IPFI. NGS-based methodologies present a promising tool for detecting IPFI, which can be a good supplement to CMT.
format Article
id doaj-art-4d1370b5f62a4a67b500e8e9e2acf4c1
institution Kabale University
issn 2235-2988
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-4d1370b5f62a4a67b500e8e9e2acf4c12025-08-20T03:48:23ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-05-011510.3389/fcimb.2025.15345191534519Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infectionsZhiyang Chen0Zhiyang Chen1Zhiyang Chen2Xin Liu3Xin Liu4Xin Liu5Li Tan6Li Tan7Li Tan8Xing Lyu9Xing Lyu10Xing Lyu11Qichen Long12Qichen Long13Qichen Long14Weimin Wu15Weimin Wu16Weimin Wu17Zhe Guo18Zhe Guo19Zhe Guo20Zhenni Liu21Zhenni Liu22Zhenni Liu23Ziyang Li24Ziyang Li25Ziyang Li26Min Hu27Min Hu28Min Hu29Department of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaDepartment of Clinical Laboratory, The Second Xiangya Hospital of Central South University, Changsha, ChinaMolecular Diagnostic Technology Hunan Engineering Research Center, Changsha, ChinaClinical Medical Research Center for Molecular Diagnosis of Infectious Diseases in Hunan Province, Changsha, ChinaObjectivesThis study aims to compare the diagnostic efficiency and consistency of metagenomic next-generation sequencing (mNGS) and targeted next-generation sequencing (tNGS) in patients with lower respiratory tract fungal infections.MethodsA total of 115 patients with probable pulmonary infection between September 2022 and April 2023 were enrolled at the Second Xiangya Hospital, Changsha, China, of which 61 were clinically diagnosed with invasive pulmonary fungal infection (IPFI) and 54 were non-IPFI cases. All patients received bronchoalveolar lavage, with mNGS, tNGS, and cultures being conducted paralleled. Diagnostic effectiveness and consistency in detecting microorganisms were compared.ResultsBoth mNGS and tNGS showed high sensitivity rates of 95.08% each, with specificity of 90.74% and 85.19%, respectively. They also demonstrated positive predictive values (PPVs) of 92.1% and 87.9% and negative predictive values (NPVs) of 94.2% and 93.9%, respectively, in diagnosing IPFI. The sensitivity and NPV of mNGS and tNGS were superior to that of any individual or combined conventional microbiological tests (CMTs) (P < 0.05). The consistency of culture with mNGS and tNGS was 48.70% and 50.43%, respectively. For fungal detection, Pneumocystis jirovecii (26/61, 42.6%; and 28/61, 45.9%), Candida albicans (19/61, 31.1%; and 21/61, 34.4%), and Aspergillus fumigatus (16/61, 26.2%; and 15/61, 24.6%) are most prevalent for mNGS and tNGS in enrolled cases, and the detection rate was greatly higher than that of culture. Furthermore, mNGS and tNGS were capable of diagnosing mixed infections in 65 and 55 out of the 115 cases, whereas only nine cases of bacterial-fungal infection were detected by culture.ConclusionThe diagnostic efficacy of mNGS and tNGS was comparable to that of identified IPFI. NGS-based methodologies present a promising tool for detecting IPFI, which can be a good supplement to CMT.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1534519/fullmNGStNGSdiagnosisinvasive pulmonary fungal infectionfungal
spellingShingle Zhiyang Chen
Zhiyang Chen
Zhiyang Chen
Xin Liu
Xin Liu
Xin Liu
Li Tan
Li Tan
Li Tan
Xing Lyu
Xing Lyu
Xing Lyu
Qichen Long
Qichen Long
Qichen Long
Weimin Wu
Weimin Wu
Weimin Wu
Zhe Guo
Zhe Guo
Zhe Guo
Zhenni Liu
Zhenni Liu
Zhenni Liu
Ziyang Li
Ziyang Li
Ziyang Li
Min Hu
Min Hu
Min Hu
Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
Frontiers in Cellular and Infection Microbiology
mNGS
tNGS
diagnosis
invasive pulmonary fungal infection
fungal
title Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
title_full Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
title_fullStr Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
title_full_unstemmed Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
title_short Comparative of metagenomic and targeted next-generation sequencing in lower respiratory tract fungal infections
title_sort comparative of metagenomic and targeted next generation sequencing in lower respiratory tract fungal infections
topic mNGS
tNGS
diagnosis
invasive pulmonary fungal infection
fungal
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1534519/full
work_keys_str_mv AT zhiyangchen comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zhiyangchen comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zhiyangchen comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT litan comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT litan comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT litan comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinglyu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinglyu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT xinglyu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT qichenlong comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT qichenlong comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT qichenlong comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT weiminwu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT weiminwu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT weiminwu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zheguo comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zheguo comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zheguo comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zhenniliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zhenniliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT zhenniliu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT ziyangli comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT ziyangli comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT ziyangli comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT minhu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT minhu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections
AT minhu comparativeofmetagenomicandtargetednextgenerationsequencinginlowerrespiratorytractfungalinfections